A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer.
Yang C, Zhang H, Chen M, Wang S, Qian R, Zhang L, Huang X, Wang J, Liu Z, Qin W, Wang C, Hang H, Wang H.
Yang C, et al. Among authors: wang h, wang j, wang s, wang c.
Elife. 2022 Feb 22;11:e71880. doi: 10.7554/eLife.71880.
Elife. 2022.
PMID: 35191375
Free PMC article.